John B.A.G. Haanen, M.D., Ph.D.

Netherlands Cancer Institute

John B.A.G. Haanen, M.D., Ph.D.

Netherlands Cancer Institute

Dr. John B. Haanen is Leader of Research Theme Immunotherapy, consultant medical oncologist and Staff Scientist in the Division of Immunology at the Netherlands Cancer Institute. He is also a Professor of Translational Immunotherapy of Cancer at the Leiden University Medical Centre, Netherlands, and serves on various national and international advisory boards and committees, including the editorial board of Current Oncology ReportsESMO Open, Kidney Cancer and is Editor-in-Chief of ESMO IOTECH, an official journal of the European Society for Medical Oncology.

Dr. Haanen was a Co-founder of the Amsterdam Biotherapeutics Unit and served as Chairman of The Dutch Tumor Immunology Working Party for oncology for many years. He is member of the board of the Dutch Melanoma Treatment Registry (DMTR) and of the European Melanoma Registry (EuMelaReg). His research focuses on the translation of novel immunotherapy strategies into the clinical practice, with special interest in cell therapies.

Dr. Haanen received his medical degree from the University of Leiden, then earned his Ph.D. with research conducted at the Department of Immunohematology and Blood Transfusion of the Leiden University Medical Centre, and at the DNAX Research Institute in California. He studied internal medicine at the Leiden University Medical Centre and at Bronovo Hospital, Netherlands, and completed a postdoctoral fellowship in tumor immunology and medical oncology at the Netherlands Cancer Institute.